Author Archives : Editorial Team

Home  >>  Author : Editorial Team

BioRN Lounge welcomed Prof. Steffen Rupp from Fraunhofer IGB

On May 17, 2018, Posted by , In Press Releases, By , With Comments Off on BioRN Lounge welcomed Prof. Steffen Rupp from Fraunhofer IGB

Heidelberg, 17.05.2018 BioRN Lounge: Prof. Steffen Rupp from Fraunhofer IGB talked about: ”Innate Immunity in 3D-Infection models: From simple Screening Systems to complex Immune Cell supplemented Skin Models” Once again, the BioRN Lounge was the occasion for the life science companies as well for scientists from our research institutes, to…

EVI: European-African partnership to advance the development of a Leishmania vaccine

On May 16, 2018, Posted by , In News, With Comments Off on EVI: European-African partnership to advance the development of a Leishmania vaccine

Phase II clinical trials in Sudan of a therapeutic vaccine to prevent post kala azar dermal leishmaniasis to be supported by European & Developing Countries Clinical Trials Partnership Heidelberg, 16 May 2018 Fresh funding from the European & Developing Countries Clinical Trials Partnership (EDCTP) has been secured by a consortium…

DKFZ: “Universal antibodies” disarm various pathogens

On May 15, 2018, Posted by , In News, With Comments Off on DKFZ: “Universal antibodies” disarm various pathogens

Scientists from the German Cancer Research Center (DKFZ) have been studying how the immune system succeeds in keeping pathogens in check. For the first time, the researchers have now discovered antibodies that are capable of disarming not only one specific bacterium but a whole variety of microorganisms at once. The…

EMBL: Celgene joins Open Targets

On May 15, 2018, Posted by , In News, With Comments Off on EMBL: Celgene joins Open Targets

May 2nd 2018 Celgene has joined Open Targets, the public-private partnership that uses human genetics and genomics data for systematic drug target identification and prioritisation Open Targets was founded in 2014 by EMBL-EBI, GSK and the Wellcome Sanger Institute The Open Targets Platform allows researchers to investigate causal links between…

NCT Heidelberg: A molecular map of childhood cancers

On March 2, 2018, Posted by , In News, By , With Comments Off on NCT Heidelberg: A molecular map of childhood cancers

Researchers led by Professor Stefan Pfister from the “Hopp Children’s Cancer Center at the NCT Heidelberg” (KiTZ) have been able to draw an extremely detailed molecular map of childhood cancers. In close collaboration with the German Cancer Consortium (DKTK) and the Society for Pediatric Oncology and Hematology (GPOH), they screened…

EMBL: New cryo-EM service at EMBL Heidelberg

On February 28, 2018, Posted by , In News, With Comments Off on EMBL: New cryo-EM service at EMBL Heidelberg

Access to state-of-the-art microscopes and outstanding expertise Felix Weis at the new cryo-EM service platform. PHOTO: Marietta Schupp/EMBL Photolab Scientists who want to obtain detailed structures of biological molecules now have a new facility to turn to: the cryo-electron microscopy (cryo-EM) service platform at EMBL Heidelberg. The platform enables scientists…

EMBL: Insights into early cell life

On February 28, 2018, Posted by , In News, With Comments Off on EMBL: Insights into early cell life

New technique that elucidates how different types of cells are made, could facilitate earlier detection of diseases Differences between cells can have significant effects during early life and in the early stages of disease Scientists in the Stegle and Marioni groups, in collaboration with scientists at the Babraham Institute and…

DKFZ: Colorectal cancer: Combined analysis enhances risk prediction

On February 28, 2018, Posted by , In News, With Comments Off on DKFZ: Colorectal cancer: Combined analysis enhances risk prediction

If first-degree relatives are affected by colorectal cancer, this indicates a person’s own elevated risk of developing bowel cancer. The same holds true for people who have large numbers of genetic risk markers in their genome. Both factors are usually used alternatively, not combined, to predict risk. Scientists from the…

DKFZ: Metastasis: Cell polarity matters

On February 28, 2018, Posted by , In News, With Comments Off on DKFZ: Metastasis: Cell polarity matters

Not only the number of migrating cancer cells determines the risk for metastasis but also their characteristics, scientists from the German Cancer Research Center (DKFZ) have now reported. For circulating cancer cells to be able to invade tissues and settle at other sites in the body, they have to exhibit…

Roche: European Commission approves Roche’s Hemlibra for people with haemophilia A with inhibitors

On February 28, 2018, Posted by , In News, With Comments Off on Roche: European Commission approves Roche’s Hemlibra for people with haemophilia A with inhibitors

First new medicine in over 20 years to treat people with haemophilia A with inhibitors in Europe Hemlibra demonstrated superior efficacy compared to prior treatment with bypassing agents in two phase III studies in adults, adolescents and children Once-weekly subcutaneous (under the skin) administration may help reduce treatment burden Roche…